Letters
Where is scientific evidence supporting EU policy on BSE and pharmaceuticals?
BMJ 1998; 316 doi: https://doi.org/10.1136/bmj.316.7131.629 (Published 14 February 1998) Cite this as: BMJ 1998;316:629
- Alan Earl-Slater, Senior lecturer in health economics
- Department of Medicines Management, Keele University, Keele, Staffordshire ST5 5BG
EDITOR—Bowser is right to attempt to provide an update of European Union (EU) policies regarding bovine spongiform encephalopathy and pharmaceuticals.1 Unfortunately his letter misses the main concern of my earlier letter2: where is the evidence supporting any of the EU's policies on bovine spongiform encephalopathy and pharmaceuticals?
Bowser is wrong to state that amendments to the EU directive on spongiform encephalopathy will not affect drugs. The commission's decision of 30 July (not 29 July as he stated) …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.